Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy

Journal of Clinical Apheresis

Volumn 21, Issue 3, 2006, Pages 181-187

  Bisaccia, Emil ^a,b   Palangio, Mark ^b   Gonzalez, Joselyn ^b   Adler, Kenneth R ^b   Scarborough, Richard ^b   Goldberg, Stuart L ^c,d   Rowley, Scott D ^c,d  

^a College of Physicians and Surgeons ^*  (United States)

^b MORRISTOWN MEMORIAL HOSPITAL   (United States)

^c HACKENSACK UNIVERSITY MEDICAL CENTER   (United States)

^d RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

Allogeneic hematopoietic stem cell transplantation; Chronic graft versus host disease; Extracorporeal photochemotherapy; Photopheresis

Indexed keywords

CYCLOSPORIN; HYDROXYCHLOROQUINE; LIVER ENZYME; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; PSORALEN; QUININE; RAPAMYCIN; TACROLIMUS;

ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTHRALGIA; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; DRY EYE; ENZYME BLOOD LEVEL; FEMALE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HUMAN; JOINT STIFFNESS; LUNG DISEASE; MALE; MOUTH DISEASE; PHOTOCHEMOTHERAPY; PUVA; THROMBOCYTOPENIA; TREATMENT DURATION; TREATMENT RESPONSE; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LIGHT; METHODOLOGY; MIDDLE AGED; TIME; TREATMENT OUTCOME;

ADULT; BONE MARROW TRANSPLANTATION; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LIGHT; MALE; MIDDLE AGED; PHOTOPHERESIS; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 33745795381     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20084     Document Type: Article

References (24)

1. Lee SJ, Vogelsang G, Flowers ME. Chronic graft-versus-host disease. Biol Blood Marrow Transplant 2003;9:215-233.
2. NCI Cancer Bulletin. Working groups discuss graft-versus-host disease. June 14, 2005. Volume 2/Number 24. NIH Publication No. 05-5498. Available at: http://www.cancer.gov.
3. Johnson ML, Farmer ER. Graft-versus-host reactions in dermatology. J Am Acad Dermatol 1998;38:369-392.
4. Bhushan V, Collins RH Jr. Chronic graft-vs-host disease. JAMA 2003;290:2599-2603.
5. Edelson R, Berger C, Gasparro F, Jegasothy B, Heald P, Wintroub B, Vonderheid E, Knobler R, Wolff K, Plewig G. Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med 1987;316:297-303.
6. Rook AH, Suchin KR, Kao DM, Yoo EK, Macey WH, DeNardo BJ, Bromley PG, Geng Y, Junkins-Hopkins JM, Lessio SR. Photopheresis: clinical applications and mechanism of action. J Investig Dermatol Symp Proc 1999;4:85-90.
7. Apisarnthanarax N, Donato M, Korbling M, Couriel D, Gajewski J, Giralt S, Khouri I, Hosing C, Champlin R, Duvic M, Anderlini P. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results. Bone Marrow Transplant 2003;31:459-465.
8. Messina C, Locatelli F, Lanino E, Oderzo C, Zacchello G, Cesaro S, Pillon M, Perotti C, Del Fante C, Faraci M, Rivabella L, Calore E, De Stefano P, Zecca M, Giorgiani G, Brugiolo A, Balduzzi A, Dini G, Zanesco L, Dall'Amico R. Extracorporeal photochemotherapy for paediatric patients with graft-versus-host disease after haematopoietic stem cell transplantation. Br J Haematol 2003;122:118-127.
9. Seaton ED, Szydlo RM, Kanfer E, Apperley JF, Russell-Jones R. Influence of extracorporeal photopheresis on clinical and laboratory parameters in chronic graft-versus-host disease and analysis of predictors of response. Blood 2003; 102:1217-1223.
10. Foss FM, Divenuti GM, Chin K, Sprague K, Grodman H, Klein A, Chan G, Stiffler K, Miller KB. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors. Bone Marrow Transplant 2005;35:1187-1193.
11. Bisaccia E, Palangio M, Gonzalez J, Adler KR, Rowley SD, Goldberg SL. Treating refractory chronic graft-versus-host disease with extracorporeal photochemotherapy. Bone Marrow Transplant 2003;31:291-294.
12. Shulman HM, Sullivan KM, Weiden PL, McDonald GB, Striker GE, Sale GE, Hackman R, Tsoi MS, Storb R, Thomas ED. Chronic graft-versus-host syndrome in man long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980;69:204-217.
13. Lee SJ. New approaches for preventing and treating chronic graft-versus-host disease. Blood 2005;105:4200-4206.
14. Akpek G, Zahurak ML, Piantadosi S, Margolis J, Doherty J, Davidson R, Vogelsang GB. Development of a prognostic model for grading chronic graft-versus-host disease. Blood 2001;97:1219-1226.
15. Clements PJ, Lachenbruch PA, Seibold JR, Zee JR, Steen VD, Brennan P, Silman AJ, Allegar N, Varga J, Massa M. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol 1993;20:1892-1896.
16. Owsianowski M, Gollnick H, Siegert W, Schwerdtfeger R, Orfanos CE. Successful treatment of chronic graft-versus-host disease with extracorporeal photopheresis. Bone Marrow Transplant 1994;14:845-848.
17. Dall'Amico R, Messina C. Extracorporeal photochemotherapy for the treatment of graft-versus-host disease. Ther Apher 2002;6:296-304.
18. Sullivan KM, Mori M, Sanders J, Siadak M, Witherspoon RP, Anasetti C, Appelbaum FR, Bensinger W, Bowden R, Buckner CD. Late complications of allogeneic and autologous marrow transplantation. Bone Marrow Transplant 1992;10(suppl. 1):127-134.
19. Martin PJ, Carpenter PA, Sanders JE, Flowers ME. Diagnosis and clinical management of chronic graft-versus-host disease. Int J Hematol 2004;79:221-228.
20. Fimiani M, Di Renzo M, Rubegni P. Mechanism of action of extracorporeal photochemotherapy in chronic graft-versus-host disease. Br J Dermatol 2004;150:1055-1060.
21. Girardi M, Herreid P, Tigelaar RE. Specific suppression of lupus-like graft-versus-host disease using extracorporeal photochemical attenuation of effector lymphocytes. J Invest Dermatol 1995;104:177-182.
22. Craciun LI, Stordeur P, Schandene L, Duvillier H, Bron D, Lambermont M, Goldman M, Dupont E. Increased production of interleukin-10 and interleukin-1 receptor antagonist after extracorporeal photochemotherapy in chronic graft-versus-host disease. Transplantation 2002;74:995-1000.
23. Di Renzo M, Rubegni P, Pasqui AL, Pompella G, De Aloe G, Sbano P, Cuccia A, Castagnini C, Auteri A, Laghi Pasini F, Fimani M. Extracorporeal photopheresis affects interleukin (IL)-10 and IL-12 production by monocytes in patients with chronic graft-versus-host disease. Br J Dermatol 2005;153:59-65.
24. Gorgun G, Miller KB, Foss FM. Immunologic mechanisms of extracorporeal photochemotherapy in chronic graft-versus-host disease. Blood 2002;100:941-947.